BOSTON -- Patients with focal segmental glomerulosclerosis (FSGS) achieved some degree of proteinuria remission more often ...

During a median follow-up period of 12.3 years, 4399 cases of diabetic microvascular complications were recorded, including 2084 cases of nephropathy, 2401 cases of retinopathy, and 831 cases of ...

Sparsentan is an endothelin and angiotensin II receptor antagonist indicated to slow kidney function decline for adults with primary IgA nephropathy who are at risk for disease progression.

"Shoppers will start seeing it at scale across the store in the next 90 days," John Ross, the CEO of Chicago-heaquartered IGA, a chain of franchised grocery stores, told CNN. There are over 1,600 ...

(G-452) Sparsentan (SPAR) as first-line treatment of incident patients with IgA nephropathy (IgAN): interim analysis of the SPARTAN trial. Presented at: National Kidney Foundation Spring Clinical ...

BOSTON—A case series that will be presented at the National Kidney Foundation Spring Clinical Meeting found sparsentan to be safe and effective in a small group of patients with immunoglobulin A ...

The IGA requires Windsor to share some of its wastewater-storage capacity with Greeley, an agreement that Greeley claims has been breached. GREELEY — The Greeley City Council voted unanimously Tuesday ...

Merida is also working on a treatment for a chronic inflammatory kidney disease called primary membranous nephropathy. “At the heart of Merida is understanding the mechanisms behind antibody ...

“Today’s approval marks an important milestone for people living with IgA nephropathy, offering a new option that can be seamlessly integrated into their existing treatment plan, with no REMS ...

Merida’s Graves’ disease program is currently in the IND-enabling stage. The biotech is also working on IgE-mediated allergic diseases and primary membranous nephropathy, both of which are still ...

IgA nephropathy, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1.

IgA nephropathy (IgAN) is characterized by the deposition of IgA1-containing immune complexes in the glomerular mesangium. The pathogenesis follows a 4-hit cascade: ...